Susquehanna Fundamental Investments, LLC Precision Biosciences Inc Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.22 - $40.8 $43,029 - $1.44 Million	-35,270 Reduced 70.91%	14,466 $19,000
Q1 2022 May 16, 2022	SELL	$2.96 - $7.76 $48,446 - $127,007	-16,367 Reduced 24.76%	49,736 $153,000
Q4 2021 Feb 14, 2022	BUY	$7.4 - $11.66 $214,422 - $337,860	28,976 Added 78.05%	66,103 $489,000
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $127,234 - $196,119	13,860 Added 59.57%	37,127 $428,000
Q2 2021 Aug 11, 2021	SELL	$8.07 - $12.52 $167,396 - $259,702	-20,743 Reduced 47.13%	23,267 $291,000
Q1 2021 May 17, 2021	BUY	$8.57 - $15.79 $377,165 - $694,917	44,010 New	44,010 $456,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.